American Century Companies’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,072
| Closed | -$85.3K | – | 2916 |
|
|
2024
Q4 | $85.3K | Sell |
10,072
-24,651
| -71% | -$209K | ﹤0.01% | 2849 |
|
|
2024
Q3 | $402K | Buy |
34,723
+5,784
| +20% | +$67K | ﹤0.01% | 2548 |
|
|
2024
Q2 | $341K | Sell |
28,939
-3,784
| -12% | -$44.6K | ﹤0.01% | 2576 |
|
|
2024
Q1 | $388K | Buy |
32,723
+3,660
| +13% | +$43.4K | ﹤0.01% | 2539 |
|
|
2023
Q4 | $356K | Buy |
29,063
+6,910
| +31% | +$84.6K | ﹤0.01% | 2493 |
|
|
2023
Q3 | $213K | Buy |
22,153
+5,707
| +35% | +$55K | ﹤0.01% | 2572 |
|
|
2023
Q2 | $148K | Buy |
+16,446
| New | +$148K | ﹤0.01% | 2600 |
|
|
2023
Q1 | – | Sell |
-522,076
| Closed | -$3.53M | – | 2683 |
|
|
2022
Q4 | $3.53M | Sell |
522,076
-629
| -0.1% | -$4.25K | ﹤0.01% | 1355 |
|
|
2022
Q3 | $7.58M | Buy |
522,705
+2,996
| +0.6% | +$43.5K | 0.01% | 986 |
|
|
2022
Q2 | $5.11M | Buy |
519,709
+35,606
| +7% | +$350K | ﹤0.01% | 1111 |
|
|
2022
Q1 | $7.14M | Buy |
484,103
+104,870
| +28% | +$1.55M | ﹤0.01% | 1009 |
|
|
2021
Q4 | $5.02M | Buy |
379,233
+104,380
| +38% | +$1.38M | ﹤0.01% | 1056 |
|
|
2021
Q3 | $4.8M | Buy |
274,853
+85
| +0% | +$1.48K | ﹤0.01% | 1032 |
|
|
2021
Q2 | $6.58M | Buy |
274,768
+56,605
| +26% | +$1.36M | ﹤0.01% | 924 |
|
|
2021
Q1 | $5.61M | Buy |
+218,163
| New | +$5.61M | ﹤0.01% | 910 |
|